Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

COMPLETED

NCT02336347

PHASE1

A Phase 1 Study Comparing AVP-786 With AVP-923

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

View on ClinicalTrials.gov

Summary

To compare pharmacokinetics (PK) of AVP-786 (deuterated \[d6\] dextromethorphan hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) to AVP-923 (dextromethorphan hydrobromide \[DM\]/Q) at steady state.

Official title: A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, 2-way Crossover Study Comparing AVP-786 With AVP-923

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2014-05-01

Completion Date

2015-03-01

Last Updated

2026-04-28

Healthy Volunteers

Yes

Conditions

Healthy Volunteer

Interventions

DRUG

AVP-786

DRUG

AVP-923

Locations (1)

Covance Dallas Clinical Research Unit

Dallas, Texas, United States